መነሻ › አኩት ማይሎይድ ሊውኬሚያ › ፍሎሪዳ

በፍሎሪዳ ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ 55 ጥናቶች በፍሎሪዳ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በፍሎሪዳ ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Moffitt Cancer Center /ID# 279192, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 2/3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07581002

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
Morton Plant Hospital, Clearwater
እና 11 ተጨማሪ

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Miami Cancer Institute, Miami
Memorial Hospital West, Pembroke Pines

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 59 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Florida Cancer Specialists & Research Institute, Fort Myers
Jupiter Research, Jupiter
AdventHealth Medical Group Blood & Marrow Transplant at Orlando, Orlando
እና 4 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

UF Health Cancer Institute - Gainesville, Gainesville
Mayo Clinic in Florida, Jacksonville
Miami Cancer Institute, Miami
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

UF Health Cancer Institute - Gainesville, Gainesville
Miami Cancer Institute, Miami

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Miami Cancer Institute, Miami
Memorial Hospital West, Pembroke Pines

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Mayo Clinic in Florida, Jacksonville
Miami Cancer Institute, Miami
Memorial Hospital West, Pembroke Pines

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 59 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
እና 10 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

6 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06504459

A Study of BGB-11417 in Participants With Myeloid Malignancies

Tampa General Hospital, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT04771130

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06616636

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Moffitt Cancer Center and Research Institute Hospital, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06969430

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Golisano Children's Hospital of Southwest Florida, Fort Myers
Nemours Children's Clinic-Jacksonville, Jacksonville
Nemours Children's Hospital, Orlando
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07022678

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Mayo Clinic, Jacksonville
Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT04588922

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

US-Jacksonville FL-MAYOFL, Jacksonville

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

US-Orlando FL-ORLANDOHEALTH, Orlando

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT07223814

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

University of Florida, Gainesville

ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ

እስከ እድሜ 50 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT05322850

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT06533761

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05886049

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
እና 9 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Golisano Children's Hospital of Southwest Florida, Fort Myers
University of Florida Health Shands Children's Hospital, Gainesville
Nemours Children's Specialty Care Jacksonville, Jacksonville
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

29 Days – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of Miami, Miami
Moffitt Cancer Center & Research Institute, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07007312

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

H Lee Moffitt Cancer Center & Research Institute, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06656494

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

University of Miami, Miami

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT07469592

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Bioresearch Partners, Miami

ተሳታዮችን በመፈለግ ላይደረጃ 2/3

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06788756

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁላይ 2026 · NCT05429632

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

University of Miami, Miami
AdventHealth Orlando, Orlando

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT05442216

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

University of Florida Shands Medical Center, Gainesville
Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
University of Miami (peds), Miami
እና 6 ተጨማሪ

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

University of Miami Health System, Coral Gables

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT05768932

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

University of Florida, Gainesville

ተሳታዮችን በመፈለግ ላይደረጃ 2

6 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT05800210

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

University of Miami - Sylvester Comprehensive Cancer Center, Miami

ተሳታዮችን በመፈለግ ላይደረጃ 2/3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኤፕሪ 2026 · NCT04256317

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

University of Miami, Miami

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT06782542

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Mayo Clinic Florida, Jacksonville

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT05732103

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT06660368

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Mayo Clinic in Florida, Jacksonville

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT06279572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

University of Miami, Miami
Miami Cancer Institute, Miami
Moffitt Cancer Center, Tampa

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

University of Miami, Miami

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።